 | • レポートコード：MRC2012A3011 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗感染薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗感染薬の種類別市場規模（OTC、処方薬）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Sanofi-Aventis、Novartis AG、Merck、Wyeth、Pfizer、Johnson、Abbott、Gilead Sciences、Bristol-Myers Squibb、Obetech、Daiichi Sankyo、Roche Pharma AG、Theravance、Optimer Pharmaceuticals、Novabay Pharmaceuticals、Nanosphere、MerLion Pharma、Basilea Pharmaceutica AG、NanoViricides、 ・地域別グローバル市場分析 2015年-2020年 ・抗感染薬の北米市場（アメリカ、カナダ、メキシコ） ・抗感染薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗感染薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗感染薬の南米市場（ブラジル、アルゼンチン） ・抗感染薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：OTC、処方薬 ・用途別分析：病院、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Drugs for Anti-Infective market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Drugs for Anti-Infective market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Drugs for Anti-Infective market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drugs for Anti-Infective market has been segmented into
OTC
Rx Drugs
By Application, Drugs for Anti-Infective has been segmented into:
Hospital
Drugs Store
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs for Anti-Infective market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs for Anti-Infective markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs for Anti-Infective market.
The report offers in-depth assessment of the growth and other aspects of the Drugs for Anti-Infective market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Drugs for Anti-Infective Market Share Analysis
Drugs for Anti-Infective competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs for Anti-Infective sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs for Anti-Infective sales, revenue and market share for each player covered in this report.
The major players covered in Drugs for Anti-Infective are:
GlaxoSmithKline
Sanofi-Aventis
Novartis AG
Merck
Wyeth
Pfizer
Johnson
Abbott
Gilead Sciences
Bristol-Myers Squibb
Obetech
Daiichi Sankyo
Roche Pharma AG
Theravance
Optimer Pharmaceuticals
Novabay Pharmaceuticals
Nanosphere
MerLion Pharma
Basilea Pharmaceutica AG
NanoViricides
Among other players domestic and global, Drugs for Anti-Infective market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Anti-Infective product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Anti-Infective, with price, sales, revenue and global market share of Drugs for Anti-Infective in 2018 and 2019.
Chapter 3, the Drugs for Anti-Infective competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Anti-Infective breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Drugs for Anti-Infective market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Drugs for Anti-Infective sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Drugs for Anti-Infective Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Anti-Infective Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Anti-Infective Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Overview of Global Drugs for Anti-Infective Market
1.4.1 Global Drugs for Anti-Infective Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi-Aventis
2.2.1 Sanofi-Aventis Details
2.2.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi-Aventis SWOT Analysis
2.2.4 Sanofi-Aventis Product and Services
2.2.5 Sanofi-Aventis Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG SWOT Analysis
2.3.4 Novartis AG Product and Services
2.3.5 Novartis AG Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Wyeth
2.5.1 Wyeth Details
2.5.2 Wyeth Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Wyeth SWOT Analysis
2.5.4 Wyeth Product and Services
2.5.5 Wyeth Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson
2.7.1 Johnson Details
2.7.2 Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson SWOT Analysis
2.7.4 Johnson Product and Services
2.7.5 Johnson Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abbott SWOT Analysis
2.8.4 Abbott Product and Services
2.8.5 Abbott Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Gilead Sciences
2.9.1 Gilead Sciences Details
2.9.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Gilead Sciences SWOT Analysis
2.9.4 Gilead Sciences Product and Services
2.9.5 Gilead Sciences Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb SWOT Analysis
2.10.4 Bristol-Myers Squibb Product and Services
2.10.5 Bristol-Myers Squibb Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Obetech
2.11.1 Obetech Details
2.11.2 Obetech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Obetech SWOT Analysis
2.11.4 Obetech Product and Services
2.11.5 Obetech Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Daiichi Sankyo
2.12.1 Daiichi Sankyo Details
2.12.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Daiichi Sankyo SWOT Analysis
2.12.4 Daiichi Sankyo Product and Services
2.12.5 Daiichi Sankyo Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Roche Pharma AG
2.13.1 Roche Pharma AG Details
2.13.2 Roche Pharma AG Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Roche Pharma AG SWOT Analysis
2.13.4 Roche Pharma AG Product and Services
2.13.5 Roche Pharma AG Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Theravance
2.14.1 Theravance Details
2.14.2 Theravance Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Theravance SWOT Analysis
2.14.4 Theravance Product and Services
2.14.5 Theravance Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Optimer Pharmaceuticals
2.15.1 Optimer Pharmaceuticals Details
2.15.2 Optimer Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Optimer Pharmaceuticals SWOT Analysis
2.15.4 Optimer Pharmaceuticals Product and Services
2.15.5 Optimer Pharmaceuticals Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Novabay Pharmaceuticals
2.16.1 Novabay Pharmaceuticals Details
2.16.2 Novabay Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Novabay Pharmaceuticals SWOT Analysis
2.16.4 Novabay Pharmaceuticals Product and Services
2.16.5 Novabay Pharmaceuticals Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Nanosphere
2.17.1 Nanosphere Details
2.17.2 Nanosphere Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Nanosphere SWOT Analysis
2.17.4 Nanosphere Product and Services
2.17.5 Nanosphere Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 MerLion Pharma
2.18.1 MerLion Pharma Details
2.18.2 MerLion Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 MerLion Pharma SWOT Analysis
2.18.4 MerLion Pharma Product and Services
2.18.5 MerLion Pharma Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Basilea Pharmaceutica AG
2.19.1 Basilea Pharmaceutica AG Details
2.19.2 Basilea Pharmaceutica AG Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Basilea Pharmaceutica AG SWOT Analysis
2.19.4 Basilea Pharmaceutica AG Product and Services
2.19.5 Basilea Pharmaceutica AG Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 NanoViricides
2.20.1 NanoViricides Details
2.20.2 NanoViricides Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 NanoViricides SWOT Analysis
2.20.4 NanoViricides Product and Services
2.20.5 NanoViricides Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Drugs for Anti-Infective Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Drugs for Anti-Infective Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Anti-Infective Manufacturer Market Share in 2019
3.3.2 Top 6 Drugs for Anti-Infective Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Drugs for Anti-Infective Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Anti-Infective Sales and Market Share by Regions (2015-2020)
4.1.2 Global Drugs for Anti-Infective Revenue and Market Share by Regions (2015-2020)
4.2 North America Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
4.3 Europe Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
4.5 South America Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Drugs for Anti-Infective Sales, Revenue and Market Share by Country
5.1.1 North America Drugs for Anti-Infective Sales and Market Share by Country (2015-2020)
5.1.2 North America Drugs for Anti-Infective Revenue and Market Share by Country (2015-2020)
5.2 United States Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
5.3 Canada Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
5.4 Mexico Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Drugs for Anti-Infective Sales, Revenue and Market Share by Country
6.1.1 Europe Drugs for Anti-Infective Sales and Market Share by Country (2015-2020)
6.1.2 Europe Drugs for Anti-Infective Revenue and Market Share by Country (2015-2020)
6.2 Germany Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
6.3 UK Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
6.4 France Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
6.5 Russia Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
6.6 Italy Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Drugs for Anti-Infective Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Drugs for Anti-Infective Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Drugs for Anti-Infective Revenue and Market Share by Regions (2015-2020)
7.2 China Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
7.3 Japan Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
7.4 Korea Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
7.5 India Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
7.7 Australia Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Drugs for Anti-Infective Sales, Revenue and Market Share by Country
8.1.1 South America Drugs for Anti-Infective Sales and Market Share by Country (2015-2020)
8.1.2 South America Drugs for Anti-Infective Revenue and Market Share by Country (2015-2020)
8.2 Brazil Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
8.3 Argentina Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Drugs for Anti-Infective Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Drugs for Anti-Infective Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Drugs for Anti-Infective Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
9.3 Turkey Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
9.4 Egypt Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
9.5 South Africa Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Drugs for Anti-Infective Sales and Market Share by Type (2015-2020)
10.2 Global Drugs for Anti-Infective Revenue and Market Share by Type (2015-2020)
10.3 Global Drugs for Anti-Infective Price by Type (2015-2020)
11 Global Drugs for Anti-Infective Market Segment by Application
11.1 Global Drugs for Anti-Infective Sales Market Share by Application (2015-2020)
11.2 Global Drugs for Anti-Infective Revenue Market Share by Application (2015-2020)
11.3 Global Drugs for Anti-Infective Price by Application (2015-2020)
12 Market Forecast
12.1 Global Drugs for Anti-Infective Sales, Revenue and Growth Rate (2021-2025)
12.2 Drugs for Anti-Infective Market Forecast by Regions (2021-2025)
12.2.1 North America Drugs for Anti-Infective Market Forecast (2021-2025)
12.2.2 Europe Drugs for Anti-Infective Market Forecast (2021-2025)
12.2.3 Asia-Pacific Drugs for Anti-Infective Market Forecast (2021-2025)
12.2.4 South America Drugs for Anti-Infective Market Forecast (2021-2025)
12.2.5 Middle East & Africa Drugs for Anti-Infective Market Forecast (2021-2025)
12.3 Drugs for Anti-Infective Market Forecast by Type (2021-2025)
12.3.1 Global Drugs for Anti-Infective Sales Forecast by Type (2021-2025)
12.3.2 Global Drugs for Anti-Infective Market Share Forecast by Type (2021-2025)
12.4 Drugs for Anti-Infective Market Forecast by Application (2021-2025)
12.4.1 Global Drugs for Anti-Infective Sales Forecast by Application (2021-2025)
12.4.2 Global Drugs for Anti-Infective Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Drugs for Anti-Infective Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs for Anti-Infective by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs for Anti-Infective Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Drugs for Anti-Infective Major Business
Table 9. GlaxoSmithKline Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 10. GlaxoSmithKline SWOT Analysis
Table 11. GlaxoSmithKline Drugs for Anti-Infective Product and Services
Table 12. GlaxoSmithKline Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi-Aventis Drugs for Anti-Infective Major Business
Table 15. Sanofi-Aventis Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 16. Sanofi-Aventis SWOT Analysis
Table 17. Sanofi-Aventis Drugs for Anti-Infective Product and Services
Table 18. Sanofi-Aventis Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis AG Drugs for Anti-Infective Major Business
Table 21. Novartis AG Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 22. Novartis AG SWOT Analysis
Table 23. Novartis AG Drugs for Anti-Infective Product and Services
Table 24. Novartis AG Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Basic Information, Manufacturing Base and Competitors
Table 26. Merck Drugs for Anti-Infective Major Business
Table 27. Merck Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 28. Merck SWOT Analysis
Table 29. Merck Drugs for Anti-Infective Product and Services
Table 30. Merck Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Wyeth Basic Information, Manufacturing Base and Competitors
Table 32. Wyeth Drugs for Anti-Infective Major Business
Table 33. Wyeth Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 34. Wyeth SWOT Analysis
Table 35. Wyeth Drugs for Anti-Infective Product and Services
Table 36. Wyeth Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Drugs for Anti-Infective Major Business
Table 39. Pfizer Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Drugs for Anti-Infective Product and Services
Table 42. Pfizer Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson Drugs for Anti-Infective Major Business
Table 45. Johnson Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 46. Johnson SWOT Analysis
Table 47. Johnson Drugs for Anti-Infective Product and Services
Table 48. Johnson Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Abbott Basic Information, Manufacturing Base and Competitors
Table 50. Abbott Drugs for Anti-Infective Major Business
Table 51. Abbott Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 52. Abbott SWOT Analysis
Table 53. Abbott Drugs for Anti-Infective Product and Services
Table 54. Abbott Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 56. Gilead Sciences Drugs for Anti-Infective Major Business
Table 57. Gilead Sciences Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 58. Gilead Sciences SWOT Analysis
Table 59. Gilead Sciences Drugs for Anti-Infective Product and Services
Table 60. Gilead Sciences Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 62. Bristol-Myers Squibb Drugs for Anti-Infective Major Business
Table 63. Bristol-Myers Squibb Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 64. Bristol-Myers Squibb SWOT Analysis
Table 65. Bristol-Myers Squibb Drugs for Anti-Infective Product and Services
Table 66. Bristol-Myers Squibb Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Obetech Basic Information, Manufacturing Base and Competitors
Table 68. Obetech Drugs for Anti-Infective Major Business
Table 69. Obetech Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 70. Obetech SWOT Analysis
Table 71. Obetech Drugs for Anti-Infective Product and Services
Table 72. Obetech Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 74. Daiichi Sankyo Drugs for Anti-Infective Major Business
Table 75. Daiichi Sankyo Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 76. Daiichi Sankyo SWOT Analysis
Table 77. Daiichi Sankyo Drugs for Anti-Infective Product and Services
Table 78. Daiichi Sankyo Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Roche Pharma AG Basic Information, Manufacturing Base and Competitors
Table 80. Roche Pharma AG Drugs for Anti-Infective Major Business
Table 81. Roche Pharma AG Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 82. Roche Pharma AG SWOT Analysis
Table 83. Roche Pharma AG Drugs for Anti-Infective Product and Services
Table 84. Roche Pharma AG Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Theravance Basic Information, Manufacturing Base and Competitors
Table 86. Theravance Drugs for Anti-Infective Major Business
Table 87. Theravance Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 88. Theravance SWOT Analysis
Table 89. Theravance Drugs for Anti-Infective Product and Services
Table 90. Theravance Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Optimer Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Optimer Pharmaceuticals Drugs for Anti-Infective Major Business
Table 93. Optimer Pharmaceuticals Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 94. Optimer Pharmaceuticals SWOT Analysis
Table 95. Optimer Pharmaceuticals Drugs for Anti-Infective Product and Services
Table 96. Optimer Pharmaceuticals Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Novabay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Novabay Pharmaceuticals Drugs for Anti-Infective Major Business
Table 99. Novabay Pharmaceuticals Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 100. Novabay Pharmaceuticals SWOT Analysis
Table 101. Novabay Pharmaceuticals Drugs for Anti-Infective Product and Services
Table 102. Novabay Pharmaceuticals Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Nanosphere Basic Information, Manufacturing Base and Competitors
Table 104. Nanosphere Drugs for Anti-Infective Major Business
Table 105. Nanosphere Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 106. Nanosphere SWOT Analysis
Table 107. Nanosphere Drugs for Anti-Infective Product and Services
Table 108. Nanosphere Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. MerLion Pharma Drugs for Anti-Infective Type and Application
Table 110. MerLion Pharma Drugs for Anti-Infective Major Business
Table 111. MerLion Pharma Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 112. MerLion Pharma SWOT Analysis
Table 113. MerLion Pharma Drugs for Anti-Infective Product and Services
Table 114. MerLion Pharma Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Basilea Pharmaceutica AG Basic Information, Manufacturing Base and Competitors
Table 116. Basilea Pharmaceutica AG Drugs for Anti-Infective Major Business
Table 117. Basilea Pharmaceutica AG Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 118. Basilea Pharmaceutica AG SWOT Analysis
Table 119. Basilea Pharmaceutica AG Drugs for Anti-Infective Product and Services
Table 120. Basilea Pharmaceutica AG Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. NanoViricides Basic Information, Manufacturing Base and Competitors
Table 122. NanoViricides Drugs for Anti-Infective Major Business
Table 123. NanoViricides Drugs for Anti-Infective Total Revenue (USD Million) (2017-2018)
Table 124. NanoViricides SWOT Analysis
Table 125. NanoViricides Drugs for Anti-Infective Product and Services
Table 126. NanoViricides Drugs for Anti-Infective Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Global Drugs for Anti-Infective Sales by Manufacturer (2018-2019) (K Units)
Table 128. Global Drugs for Anti-Infective Revenue by Manufacturer (2018-2019) (USD Million)
Table 129. Global Drugs for Anti-Infective Sales by Regions (2015-2020) (K Units)
Table 130. Global Drugs for Anti-Infective Sales Market Share by Regions (2015-2020)
Table 131. Global Drugs for Anti-Infective Revenue by Regions (2015-2020) (USD Million)
Table 132. North America Drugs for Anti-Infective Sales by Countries (2015-2020) (K Units)
Table 133. North America Drugs for Anti-Infective Sales Market Share by Countries (2015-2020)
Table 134. North America Drugs for Anti-Infective Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Drugs for Anti-Infective Revenue Market Share by Countries (2015-2020)
Table 136. Europe Drugs for Anti-Infective Sales by Countries (2015-2020) (K Units)
Table 137. Europe Drugs for Anti-Infective Sales Market Share by Countries (2015-2020)
Table 138. Europe Drugs for Anti-Infective Revenue by Countries (2015-2020) (USD Million)
Table 139. Asia-Pacific Drugs for Anti-Infective Sales by Regions (2015-2020) (K Units)
Table 140. Asia-Pacific Drugs for Anti-Infective Sales Market Share by Regions (2015-2020)
Table 141. Asia-Pacific Drugs for Anti-Infective Revenue by Regions (2015-2020) (USD Million)
Table 142. South America Drugs for Anti-Infective Sales by Countries (2015-2020) (K Units)
Table 143. South America Drugs for Anti-Infective Sales Market Share by Countries (2015-2020)
Table 144. South America Drugs for Anti-Infective Revenue by Countries (2015-2020) (USD Million)
Table 145. South America Drugs for Anti-Infective Revenue Market Share by Countries (2015-2020)
Table 146. Middle East & Africa Drugs for Anti-Infective Sales by Countries (2015-2020) (K Units)
Table 147. Middle East & Africa Drugs for Anti-Infective Sales Market Share by Countries (2015-2020)
Table 148. Middle East & Africa Drugs for Anti-Infective Revenue by Countries (2015-2020) (USD Million)
Table 149. Middle East & Africa Drugs for Anti-Infective Revenue Market Share by Countries (2015-2020)
Table 150. Global Drugs for Anti-Infective Sales by Type (2015-2020) (K Units)
Table 151. Global Drugs for Anti-Infective Sales Share by Type (2015-2020)
Table 152. Global Drugs for Anti-Infective Revenue by Type (2015-2020) (USD Million)
Table 153. Global Drugs for Anti-Infective Revenue Share by Type (2015-2020)
Table 154. Global Drugs for Anti-Infective Sales by Application (2015-2020) (K Units)
Table 155. Global Drugs for Anti-Infective Sales Share by Application (2015-2020)
Table 156. Global Drugs for Anti-Infective Sales Forecast by Regions (2021-2025) (K Units)
Table 157. Global Drugs for Anti-Infective Market Share Forecast by Regions (2021-2025)
Table 158. Global Drugs for Anti-Infective Sales Forecast by Type (2021-2025) (K Units)
Table 159. Global Drugs for Anti-Infective Market Share Forecast by Type (2021-2025)
Table 160. Global Drugs for Anti-Infective Sales Forecast by Application (2021-2025)
Table 161. Global Drugs for Anti-Infective Market Share Forecast by Application (2021-2025)
Table 162. Direct Channel Pros & Cons
Table 163. Indirect Channel Pros & Cons
Table 164. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Drugs for Anti-Infective Picture
Figure 2. Global Sales Market Share of Drugs for Anti-Infective by Type in 2019
Figure 3. OTC Picture
Figure 4. Rx Drugs Picture
Figure 5. Drugs for Anti-Infective Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Drugs Store Picture
Figure 8. Other Picture
Figure 9. Global Drugs for Anti-Infective Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Drugs for Anti-Infective Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Drugs for Anti-Infective Sales Market Share by Manufacturer in 2019
Figure 30. Global Drugs for Anti-Infective Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Drugs for Anti-Infective Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Drugs for Anti-Infective Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Drugs for Anti-Infective Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Drugs for Anti-Infective Revenue Market Share by Regions (2015-2020)
Figure 37. Global Drugs for Anti-Infective Revenue Market Share by Regions in 2018
Figure 38. North America Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
Figure 39. Europe Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
Figure 41. South America Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Drugs for Anti-Infective Sales and Growth Rate (2015-2020)
Figure 43. North America Drugs for Anti-Infective Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Drugs for Anti-Infective Sales Market Share by Countries (2015-2020)
Figure 45. North America Drugs for Anti-Infective Sales Market Share by Countries in 2018
Figure 46. North America Drugs for Anti-Infective Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Drugs for Anti-Infective Revenue Market Share by Countries in 2018
Figure 48. United States Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Drugs for Anti-Infective Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Drugs for Anti-Infective Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Drugs for Anti-Infective Revenue Market Share by Countries in 2019
Figure 54. Germany Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Drugs for Anti-Infective Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Drugs for Anti-Infective Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Drugs for Anti-Infective Revenue Market Share by Regions 2019
Figure 62. China Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Drugs for Anti-Infective Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Drugs for Anti-Infective Sales Market Share by Countries in 2019
Figure 69. South America Drugs for Anti-Infective Revenue Market Share by Countries in 2019
Figure 70. Brazil Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Drugs for Anti-Infective Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Drugs for Anti-Infective Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Drugs for Anti-Infective Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Drugs for Anti-Infective Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Drugs for Anti-Infective Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Drugs for Anti-Infective Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Drugs for Anti-Infective Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Drugs for Anti-Infective Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Drugs for Anti-Infective Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Drugs for Anti-Infective Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Drugs for Anti-Infective Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Drugs for Anti-Infective Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
抗感染症薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Infective Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Infective Drugs mar…- 抗感染症薬の世界市場（～2026年） Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro p…
- 眼感染症の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Anti-infective Ophthalmic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 薬物・抗感染症の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drug, Anti-infective market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug, Anti-infective mar…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…